Accretion Pharmaceuticals Limited (NSEI: ACCPL)
Health Care · Pharmaceuticals · IN
Rs188.95
-7.06% today · +221.9% 1Y
Accretion Pharmaceuticals Limited (NSEI: ACCPL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $21.70M.
Over the last twelve months the share price has gained 221.9%, trading between 53.80 and 220.00.
Tweenvest scores Accretion Pharmaceuticals Limited across four factors: quality 65/100, value 28/100. Its strongest factor is quality.
ACCPL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.70M
- Revenue (TTM)
- $9.56M
- P/E
- 20.92
- EPS
- 9.03
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs220.00
- 52-week low
- Rs53.80
- Avg volume (3M)
- —
- Shares outstanding
- 11.12M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Provectus Biopharmaceuticals, Inc.OTCPK: PVCT | $22.23M | $0.05 | -2.76% |
| Sat Kartar Life LimitedNSEI: SATKARTAR | $22.22M | Rs136.60 | -25.80% |
| Neurothera Labs Inc.TSXV: NTLX | $22.17M | CA$2.30 | -47.73% |
| Aytu BioPharma, Inc.NasdaqCM: AYTU | $22.01M | $2.03 | -2.17% |
| Accretion Nutraveda LimitedBSE: 544694 | $21.69M | Rs290.00 | -4.92% |
| Public Joint-Stock Company "Pharmsynthez"MISX: LIFE | $21.52M | RUB— | — |
| Rubicon Organics Inc.TSXV: ROMJ | $21.31M | CA$0.45 | +2.27% |
| Philadelphia Pharmaceuticals CompanyASE: PHIL | $21.16M | JD2.00 | +5.26% |
Figures last refreshed Oct 11, 2026.